3,4-dihydroxyphenylglycol has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biaggioni, I; Brown, RT; Garty, M; Goldstein, DS; Kopin, IJ; Polinsky, RJ; Robertson, D; Stull, R | 1 |
| Laverty, R; Logan, BJ; Sanderson, WD; Yee, YB | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylglycol and Nervous System Disorders
| Article | Year |
|---|---|
Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Catecholamines; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Methoxyhydroxyphenylglycol; Middle Aged; Nervous System Diseases; Norepinephrine; Sympathetic Nervous System | 1989 |
Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Monoamines; Dopamine; Male; Methoxyhydroxyphenylglycol; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Norepinephrine; Rats; Species Specificity | 1988 |